Key result
Among 6 patients receiving the 3F-Enable sutureless aortic valve prosthesis, 4 were alive and asymptomatic at 1 year, with a mean pressure gradient of 6.8 mmHg and aortic valve area of 2.2 cm2.
Population
6 patients with symptomatic aortic stenosis (NYHA III), mean age 74+/-1.8 years, 3 females.
Design
Case_series
Follow-up
12 months
Authors
Loading...
Supports early feasibility of sutureless valves in small series; leaves open durability, leakage rates, and need for larger trials.
Case Report (n=6)
Initial experience with the 3F-Enable sutureless aortic valve prosthesis demonstrates feasibility and good hemodynamics, but highlights significant issues with paravalvular leakage requiring device enhancements.
Wendt et al. (2008) conducted a case report in Symptomatic aortic stenosis (NYHA III) (n=6). 3F-Enable sutureless aortic valve prosthesis was evaluated on Clinical data, adverse events, and patient outcome at 1 year. Among 6 patients receiving the 3F-Enable sutureless aortic valve prosthesis, 4 were alive and asymptomatic at 1 year, with a mean pressure gradient of 6.8 mmHg and aortic valve area of 2.2 cm2.